Oncogenesis addiction, biomarkers: Who should be tested and when?

Date 27 September 2014
Event ESMO 2014
Session Systemic treatment of metastatic NSCLC
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Personalised Medicine
Presenter Pasi Janne
Authors P.A. Janne
  • Thoracic Oncology, Dana-Farber Cancer Institute, 02215 - Boston/US